Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan · Delayed Price · Currency is TWD 397.50
-2.50 (-0.63%)
Apr 17, 2026, 1:11 PM CST
Sunmax Biotechnology Market Cap
Sunmax Biotechnology has a market cap or net worth of 21.65 billion as of April 17, 2026. Its market cap has increased by 22.69% in one year.
Market Cap
21.65B
Enterprise Value
20.81B
Revenue
2.03B
Ranking
n/a
PE Ratio
29.86
Stock Price
397.50
Market Cap Chart
Since January 25, 2010, Sunmax Biotechnology's market cap has increased from 1.49B to 21.65B, an increase of 1,355.80%. That is a compound annual growth rate of 17.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 21.65B | 0.38% |
| Dec 31, 2025 | 21.57B | 41.43% |
| Dec 30, 2024 | 15.25B | 37.25% |
| Dec 29, 2023 | 11.11B | 50.00% |
| Dec 30, 2022 | 7.41B | 64.65% |
| Dec 30, 2021 | 4.50B | 2.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 35.82B |
| Oneness Biotech | 26.07B |
| Lumosa Therapeutics | 21.94B |
| AP Biosciences | 16.69B |
| Polaris Group | 16.17B |
| Medigen Vaccine Biologics | 15.78B |
| EirGenix | 15.31B |
| TaiMed Biologics | 14.56B |